市場調查報告書
商品編碼
1306973
全球中央實驗室市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023至2030年預測Global Central Lab Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
預計到2030年,全球中心實驗室市場需求將從2022年的40.4億美元成長至72億美元,2023-2030年複合年成長率為7.5%。
中心實驗室通常與製藥公司、契約研究組織(CRO)或學術機構簽訂契約,為分佈在不同地點的多個臨床試驗機構進行實驗室測試。使用中心實驗室的目的是確保樣本分析的標準化和一致性,最大限度地減少每個試驗點自行檢測可能出現的差異。
製藥行業投入巨資研發新藥和新療法,導致對實驗室服務的需求增加。臨床試驗對於藥物開發過程非常重要。中心實驗室可提供一系列服務來支持臨床試驗,如樣本採集、處理和分析。此外,個性化醫療需要更複雜的實驗室檢測方法,而中心實驗室可以提供這種服務。中心實驗室採用自動化和人工智慧技術來提高效率和準確性。這導致對其服務的需求增加。然而,醫療保健行業受到嚴格的監管,這可能使中心實驗室的營運變得困難且成本高昂。此外,醫院和診所擴大提供實驗室服務,這可能會對市場產生負面影響。
本研究涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構,評估全球範圍內的競爭吸引力。此外,這些工具還對全球中心實驗室市場的各個細分市場進行了全面評估。中心實驗室行業的成長和趨勢為本研究提供了整體方法。
這部分涵蓋了區域前景,重點分析了北美、歐洲、亞太、拉丁美洲、中東和非洲地區對中心實驗室市場的當前和未來需求。此外,這部分還重點分析了所有主要地區各個應用領域的需求、估計和預測。
本研究還涵蓋了市場主要參與者的綜合概況以及全球競爭格局的深入分析。中心實驗室市場的主要參與者包括:ACM Global Laboratories、Labconnect、Cerba Research、Eurofins Scientific、Medicover Integrated Clinical Services、Versiti、AP Møller Holding A/S、Ampersand Capital Partners、Lambda Therapeutic Research Ltd、Cirion Biopharma Research Inc.。本部分包括競爭格局的整體視圖,其中包括各種戰略發展,如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品上市和其他發展。
如果您有任何客製化要求,請聯繫我們。我們的研究團隊可以根據您的需求提供客製化服務。
The global demand for Central Lab Market is presumed to reach the market size of nearly USD 7.2 BN by 2030 from USD 4.04 BN in 2022 with a CAGR of 7.5% under the study period 2023 - 2030.
Central labs are typically contracted by pharmaceutical companies, contract research organizations (CROs), or academic institutions to conduct laboratory testing for multiple clinical trial sites spread across different locations. The purpose of using a central lab is to ensure standardized and consistent analysis of samples, minimizing variations that could occur if each site performed its own testing.
The pharmaceutical industry is investing heavily in R&D to develop new drugs and treatments, leading to an increased demand for laboratory services. Clinical trials are critical for the drug development process. Central labs can provide a range of services to support clinical trials, such as sample collection, processing, and analysis. Moreover, personalized medicine requires a more sophisticated approach to laboratory testing, which central labs can provide. Central labs are adopting automation and artificial intelligence to improve efficiency and accuracy. This is leading to increased demand for their services. However, the healthcare industry is subject to stringent regulations, which can make central labs operation difficult and costly. Also, hospitals and clinics are increasingly offering laboratory services which may affect the market negatively.
The research covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of central lab. The growth and trends of central lab industry provide a holistic approach to this study.
This section of the central lab market provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Central Lab market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the central lab market include ACM Global Laboratories; Labconnect; Cerba Research; Eurofins Scientific; Medicover Integrated Clinical Services; Versiti; A.P. Møller Holding A/S; Ampersand Capital Partners; Lambda Therapeutic Research Ltd; Cirion Biopharma Research Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized as per your need.